An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease

Preclinical data have shown that rilmenidine can regulate autophagy in models of Huntington’s disease (HD), providing a potential route to alter the disease course in patients. Consequently, a 2-year open-label study examining the tolerability and feasibility of rilmenidine in mild-moderate HD was u...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurol
Main Authors: Underwood, Benjamin R., Green-Thompson, Zeyn W., Pugh, Peter J., Lazic, Stanley E., Mason, Sarah L., Griffin, Jules, Jones, P. Simon, Rowe, James B., Rubinsztein, David C., Barker, Roger A.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2017
Assuntos:
Original Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5688221/
https://ncbi.nlm.nih.gov/pubmed/29075837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-017-8647-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados